The effect of a high-polyphenol Mediterranean diet (Green-MED) combined with physical activity on age-related brain atrophy: the Dietary Intervention Randomized Controlled Trial Polyphenols Unprocessed Study (DIRECT PLUS).
Green Mediterranean diet
age-related atrophy
aging
dietary intervention
hippocampal occupancy score
neurodegeneration
polyphenols
Journal
The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027
Informations de publication
Date de publication:
01 05 2022
01 05 2022
Historique:
received:
12
09
2021
accepted:
08
01
2022
pubmed:
13
1
2022
medline:
10
5
2022
entrez:
12
1
2022
Statut:
ppublish
Résumé
The effect of diet on age-related brain atrophy is largely unproven. We aimed to explore the effect of a Mediterranean diet (MED) higher in polyphenols and lower in red/processed meat (Green-MED diet) on age-related brain atrophy. This 18-mo clinical trial longitudinally measured brain structure volumes by MRI using hippocampal occupancy score (HOC) and lateral ventricle volume (LVV) expansion score as neurodegeneration markers. Abdominally obese/dyslipidemic participants were randomly assigned to follow 1) healthy dietary guidelines (HDG), 2) MED, or 3) Green-MED diet. All subjects received free gym memberships and physical activity guidance. Both MED groups consumed 28 g walnuts/d (+440 mg/d polyphenols). The Green-MED group consumed green tea (3-4 cups/d) and Mankai (Wolffia-globosa strain, 100 g frozen cubes/d) green shake (+800 mg/d polyphenols). Among 284 participants (88% men; mean age: 51 y; BMI: 31.2 kg/m2; APOE-ε4 genotype = 15.7%), 224 (79%) completed the trial with eligible whole-brain MRIs. The pallidum (-4.2%), third ventricle (+3.9%), and LVV (+2.2%) disclosed the largest volume changes. Compared with younger participants, atrophy was accelerated among those ≥50 y old (HOC change: -1.0% ± 1.4% compared with -0.06% ± 1.1%; 95% CI: 0.6%, 1.3%; P < 0.001; LVV change: 3.2% ± 4.5% compared with 1.3% ± 4.1%; 95% CI: -3.1%, -0.8%; P = 0.001). In subjects ≥ 50 y old, HOC decline and LVV expansion were attenuated in both MED groups, with the best outcomes among Green-MED diet participants, as compared with HDG (HOC: -0.8% ± 1.6% compared with -1.3% ± 1.4%; 95% CI: -1.5%, -0.02%; P = 0.042; LVV: 2.3% ± 4.7% compared with 4.3% ± 4.5%; 95% CI: 0.3%, 5.2%; P = 0.021). Similar patterns were observed among younger subjects. Improved insulin sensitivity over the trial was the parameter most strongly associated with brain atrophy attenuation (P < 0.05). Greater Mankai, green tea, and walnut intake and less red and processed meat were significantly and independently associated with reduced HOC decline (P < 0.05). Elevated urinary concentrations of the polyphenols urolithin-A (r = 0.24; P = 0.013) and tyrosol (r = 0.26; P = 0.007) were significantly associated with lower HOC decline. A Green-MED (high-polyphenol) diet, rich in Mankai, green tea, and walnuts and low in red/processed meat, is potentially neuroprotective for age-related brain atrophy.This trial was registered at clinicaltrials.gov as NCT03020186.
Sections du résumé
BACKGROUND
The effect of diet on age-related brain atrophy is largely unproven.
OBJECTIVES
We aimed to explore the effect of a Mediterranean diet (MED) higher in polyphenols and lower in red/processed meat (Green-MED diet) on age-related brain atrophy.
METHODS
This 18-mo clinical trial longitudinally measured brain structure volumes by MRI using hippocampal occupancy score (HOC) and lateral ventricle volume (LVV) expansion score as neurodegeneration markers. Abdominally obese/dyslipidemic participants were randomly assigned to follow 1) healthy dietary guidelines (HDG), 2) MED, or 3) Green-MED diet. All subjects received free gym memberships and physical activity guidance. Both MED groups consumed 28 g walnuts/d (+440 mg/d polyphenols). The Green-MED group consumed green tea (3-4 cups/d) and Mankai (Wolffia-globosa strain, 100 g frozen cubes/d) green shake (+800 mg/d polyphenols).
RESULTS
Among 284 participants (88% men; mean age: 51 y; BMI: 31.2 kg/m2; APOE-ε4 genotype = 15.7%), 224 (79%) completed the trial with eligible whole-brain MRIs. The pallidum (-4.2%), third ventricle (+3.9%), and LVV (+2.2%) disclosed the largest volume changes. Compared with younger participants, atrophy was accelerated among those ≥50 y old (HOC change: -1.0% ± 1.4% compared with -0.06% ± 1.1%; 95% CI: 0.6%, 1.3%; P < 0.001; LVV change: 3.2% ± 4.5% compared with 1.3% ± 4.1%; 95% CI: -3.1%, -0.8%; P = 0.001). In subjects ≥ 50 y old, HOC decline and LVV expansion were attenuated in both MED groups, with the best outcomes among Green-MED diet participants, as compared with HDG (HOC: -0.8% ± 1.6% compared with -1.3% ± 1.4%; 95% CI: -1.5%, -0.02%; P = 0.042; LVV: 2.3% ± 4.7% compared with 4.3% ± 4.5%; 95% CI: 0.3%, 5.2%; P = 0.021). Similar patterns were observed among younger subjects. Improved insulin sensitivity over the trial was the parameter most strongly associated with brain atrophy attenuation (P < 0.05). Greater Mankai, green tea, and walnut intake and less red and processed meat were significantly and independently associated with reduced HOC decline (P < 0.05). Elevated urinary concentrations of the polyphenols urolithin-A (r = 0.24; P = 0.013) and tyrosol (r = 0.26; P = 0.007) were significantly associated with lower HOC decline.
CONCLUSIONS
A Green-MED (high-polyphenol) diet, rich in Mankai, green tea, and walnuts and low in red/processed meat, is potentially neuroprotective for age-related brain atrophy.This trial was registered at clinicaltrials.gov as NCT03020186.
Identifiants
pubmed: 35021194
pii: S0002-9165(22)00250-7
doi: 10.1093/ajcn/nqac001
pmc: PMC9071484
doi:
Substances chimiques
Polyphenols
0
Tea
0
Banques de données
ClinicalTrials.gov
['NCT03020186']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1270-1281Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.
Références
Public Health Nutr. 2004 Sep;7(6):745-9
pubmed: 15369612
Neuroimage. 2010 Jul 1;51(3):943-51
pubmed: 20211265
Eur J Nutr. 2019 Feb;58(1):113-130
pubmed: 29151137
Hum Brain Mapp. 2018 Jun;39(6):2500-2513
pubmed: 29468773
J Clin Med. 2020 Mar 19;9(3):
pubmed: 32204500
Am J Geriatr Psychiatry. 2015 May;23(5):456-65
pubmed: 25306196
Diabetes Care. 2016 May;39(5):764-71
pubmed: 27208378
Neurochem Int. 2015 Oct;89:157-69
pubmed: 25959627
Neurobiol Aging. 2012 May;33(5):845-55
pubmed: 20855131
JAMA Intern Med. 2015 Jul;175(7):1094-1103
pubmed: 25961184
J Nutr. 2005 Mar;135(3):573-9
pubmed: 15735096
Nat Rev Neurosci. 2010 May;11(5):339-50
pubmed: 20354534
Obesity (Silver Spring). 2008 Jan;16(1):119-24
pubmed: 18223623
Front Neurosci. 2020 Aug 12;14:786
pubmed: 32903442
Database (Oxford). 2013 Oct 07;2013:bat070
pubmed: 24103452
Am J Clin Nutr. 2018 Mar 1;107(3):389-404
pubmed: 29566197
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
Nutr Neurosci. 2019 Mar;22(3):185-195
pubmed: 28784051
Nutr Diabetes. 2018 Mar 9;8(1):13
pubmed: 29549354
Alzheimers Dement. 2018 Jul;14(7):902-912
pubmed: 29605385
Clin Nutr. 2019 Dec;38(6):2576-2582
pubmed: 30591380
Arch Neurol. 2005 Oct;62(10):1556-60
pubmed: 16216938
Behav Res Methods. 2019 Feb;51(1):40-60
pubmed: 30022459
Ann Neurol. 2016 Jun;79(6):1014-25
pubmed: 27129740
Int J Mol Sci. 2020 Apr 09;21(7):
pubmed: 32283806
Am J Clin Nutr. 2010 Oct;92(4):801-9
pubmed: 20810980
Rev Neurosci. 2019 Dec 18;31(1):1-57
pubmed: 31194693
Bull Exp Biol Med. 2019 Dec;168(2):224-228
pubmed: 31776958
Neurology. 2015 Nov 17;85(20):1744-51
pubmed: 26491085
BMC Geriatr. 2019 Feb 28;19(1):59
pubmed: 30819102
J Nutr. 2019 Jun 1;149(6):1004-1011
pubmed: 30915471
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Neurology. 2013 Sep 3;81(10):904-9
pubmed: 23925758
J Neuropsychiatry Clin Neurosci. 2015;27(2):147-52
pubmed: 25923853
Nutrients. 2021 May 30;13(6):
pubmed: 34070816
Neurology. 2011 Oct 25;77(17):1619-28
pubmed: 21998317
Neuroimage Clin. 2019;23:101904
pubmed: 31254939
Assessment. 2022 Jun;29(4):717-730
pubmed: 33522278
Neurology. 2017 Jan 31;88(5):449-455
pubmed: 28053008
Gut. 2021 Nov;70(11):2085-2095
pubmed: 33461965
Mol Aspects Med. 2012 Feb;33(1):83-97
pubmed: 22107709
Epidemiology. 1996 Jan;7(1):81-6
pubmed: 8664406
AJNR Am J Neuroradiol. 2000 Jan;21(1):112-8
pubmed: 10669234
Nature. 1971 Aug 13;232(5311):495
pubmed: 4937216
Am J Clin Nutr. 2020 Mar 1;111(3):590-600
pubmed: 31912155
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3017-22
pubmed: 21282661
Nutrients. 2020 Feb 20;12(2):
pubmed: 32093220
J Am Coll Cardiol. 2020 May 26;75(20):2525-2534
pubmed: 32439001
Rejuvenation Res. 2009 Dec;12(6):445-53
pubmed: 20041738
J Neuroinflammation. 2019 Mar 14;16(1):62
pubmed: 30871577
Oxid Med Cell Longev. 2012;2012:541971
pubmed: 22829957
Circulation. 2018 Mar 13;137(11):1143-1157
pubmed: 29142011
Diabetes Care. 2019 Jul;42(7):1162-1169
pubmed: 31076421
Am J Epidemiol. 2007 Jun 15;165(12):1364-71
pubmed: 17369607